News

Slow Walking, Cognitive Issues May Predict Alzheimer’s Risk

A simple test that measures how fast people walk and whether they have cognitive issues can determine how likely they are to develop dementia, which includes diseases such as Alzheimer’s, within 12 years. These are the conclusions of a study led by scientists at the Albert Einstein College of…

Prana Biotechnology’s PBT2 Trial Provides Further Data On Treating Alzheimer’s Disease

Recent results from Prana Biotechnology’s IMAGINE Alzheimer’s trial, released earlier this year (March), as well as the company’s ongoing sub-analysis, has suggested to the company’s research team that further analysis of the PiB-PET Standardized Uptake Value Ratio (SUVR) and the tendency towards preservation of brain volume in PBT2 treated patients may be necessary. The results…

Depression And Dementia May Be Related, Study Suggests

A team of researchers who conducted an eight-year study of elderly people believe they have found a relationship between depression and dementia that suggests that treating the first can reduce a part of the effects of the second. The study, published in the journal Neurology, indicates that older people…

Scientists Evaluate Cancer Drug’s Potential On Alzheimer’s

A group of scientists is researching the possibility of utilizing a set of compounds developed for cancer treatment as a novel oral therapy for treating Alzheimer’s disease. Up until now, the team had only tested and evaluated injected epothilone D, a brain-penetrant MT-stabilizer, in mice and AD patients. However, in spite of the fact…

Aduhelm Approved